Author details

Full Name

B K Rasheed

Affiliation

ORCID

Career Start Year

1991

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
25598002	Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.	J Neurochem	2015
24722048	Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas.	Oncotarget	2014
24140581	The genetic landscape of anaplastic astrocytoma.	Oncotarget	2014
23204232	Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.	Cancer Research	2013
23530248	TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.	Proc Natl Acad Sci U S A	2013
23592488	Exomic sequencing of four rare central nervous system tumor types.	Oncotarget	2013
22869205	Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.	Oncotarget	2012
21719641	Altered telomeres in tumors with ATRX and DAXX mutations.	Science	2011
21163964	The genetic landscape of the childhood cancer medulloblastoma.	Science	2011
22112477	Central nervous system.	Cancer Biomarkers	2010
20809959	MRP3: a molecular target for human glioblastoma multiforme immunotherapy.	BMC Cancer	2010
19920201	Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress.	Cancer Research	2009
19228619	IDH1 and IDH2 mutations in gliomas.	N Engl J Med	2009
18772396	An integrated genomic analysis of human glioblastoma multiforme.	Science	2008
18676759	Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.	Clinical Cancer Research	2008
16951188	AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.	Cancer Res	2006
16299247	ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.	Clin Cancer Res	2005
15899794	Gene expression profiling and genetic markers in glioblastoma survival.	Cancer Res	2005
16116609	Survival analysis of presumptive prognostic markers among oligodendrogliomas.	Cancer	2005
15105803	Correlation of 1p-19q-defects in human gliomas with the light microscopic appearance of oligodendroglioma.	Modern Pathology	2004
15376352	EGFR mutations and sensitivity to gefitinib.	N Engl J Med	2004
12173338	Molecular markers of prognosis in astrocytic tumors.	Cancer	2002
11302337	Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification.	Neuro-Oncology	2000
10631867	Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit.	American Journal of Clinical Pathology	2000
10787031	Characterization of chromosome 17 abnormalities in medulloblastomas.	Acta Neuropathologica	2000
10433931	Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.	American Journal of Pathology	1999
11550302	Morphologic and molecular genetic aspects of oligodendroglial neoplasms.	Neuro-Oncology	1999
10328589	Molecular pathogenesis of malignant gliomas.	Current Opinion in Oncology	1999
9230204	Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.	Cancer Res	1997
9331072	PTEN gene mutations are seen in high-grade but not in low-grade gliomas.	Cancer Research	1997
8781970	In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.	Glycoconj J	1996
8824726	Microsatellite analysis of childhood brain tumors.	Genes Chromosomes and Cancer	1996
7784070	Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.	Oncogene	1995
8118823	Alterations of the TP53 gene in human gliomas.	Cancer Research	1994
7967518	Oncogenes and anti-oncogenes in human central nervous system tumors.	Laboratory Investigation	1994
1737373	Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines.	Cancer Research	1992
1384665	Loss of heterozygosity for 10q loci in human gliomas.	Genes Chromosomes Cancer	1992
1893534	Expression of O6-methylguanine-DNA methyltransferase in malignant human glioma cell lines.	Carcinogenesis	1991
1786630	Genetic alterations in glioma and medulloblastoma.	Cancer and Metastasis Reviews	1991